| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |